Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › rAAV vectors for the treatment of GM1 and GM2 gangliosidosis

rAAV vectors for the treatment of GM1 and GM2 gangliosidosis

US Patent 12448629 · Granted Oct 21, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicistronic AAV vectors encoding hexosaminidase alpha and beta-subunits and uses2025
Heterologous targeting peptide grafted AAVs2025
High efficiency library-identified AAV vectors2024
AAV capsids identified by in vivo library selection2024
Method to enhance the efficiency of systemic AAV gene delivery to the central ne2023
Self-regulating AAV vectors for safe expression of MeCP2 in rett syndrome2023
AAV capsids identified by in vivo library selection2022
AAV vectors encoding NF1 and uses thereof2022
Modulation of AAV vector transgene expression2021
Heterologous targeting peptide grafted AAVS2021
High efficiency library-identified AAV vectors2020
Heterologous targeting peptide grafted AAVS2019